The NCAA, which has been sued dozens of times for its role in handling concussions, will help fund an expanded $22.5 million study to examine the impacts of head injuries.
Two reports, sponsored by the Richard M. Fairbanks Foundation, say the state should not let up in fighting twin scourges that claim thousands of lives and cost billions of dollars in health care costs and lost productivity.
Much of the insurance left on the Affordable Care Act marketplaces limits patients to narrow networks of hospitals or doctors and provides no coverage outside those networks.
President Donald Trump said he was “taking aim at the global freeloading that forces American consumers to subsidize lower prices in foreign countries through higher prices in our country.”
President Donald Trump is linking the drug prices Americans complain about to one of his longstanding grievances: foreign countries the president says are taking advantage of U.S. research breakthroughs.
Indiana University Health Physicians is setting its sights on one of the state’s last independent specialty holdouts, the neurosurgical Goodman Campbell Brain and Spine.
The plan approved by Purdue trustees on Oct. 12 met widespread opposition from faculty and staff.
The experimental drug eased arthritis pain in hard-to-treat patients without major safety concerns, a key step in creating a new class of medications that may one day offer an alternative to narcotics.
Seema Verma, administrator for the Centers for Medicare and Medicaid Services and former health consultant to Mitch Daniels and Mike Pence, visited Indianapolis on Monday to drum up excitement for the program, which now covers about 20 million Americans.
Purdue University is joining a trend among large employers by limiting health care coverage for working spouses of the school's faculty and staff.
Indiana lawmakers listened to more than three hours of testimony Thursday afternoon about whether Indiana should allow for medical marijuana usage but did not come to any consensus on the issue.
The Treasury pilot program implements broader powers Congress granted this year to the Committee on Foreign Investment in the U.S., a panel of officials who review foreign takeover of American firms and can recommend that the president block deals that threaten national security.
The West Lafayette biotech firm’s stock traded as low as $1.41 last fall, following multiple setbacks and restructurings. But the stock had soared to $24 Thursday morning after news that it would be acquired by Novartis.
One year ago, Indiana-based Endocyte Inc. bought the rights to a prostate cancer treatment for $12 million, plus future considerations. On Thursday, Novartis AG agreed to pay almost 200 times that amount to acquire Endocyte and the experimental therapy.
The deal represents a huge breakthrough for tiny Endocyte, which has about 90 employees in Indiana but has not yet launched a single product.
The agency said Indiana workers' compensation rates have been on a downward trend for several years because of fewer worker injuries and growing payrolls.
The standalone, two-story facility is expected to offer a wide array of inpatient and outpatient services, including addiction treatment, counseling and psychiatric intensive care.
The drug industry's main trade group said drug companies are only willing to disclose the prices on their websites, not in commercials, and they'll start doing that next spring.
The nation’s second-largest health insurer has agreed to pay the government a record amount to settle potential privacy violations in the biggest known health care hack in U.S. history, officials said Monday.
Shares in Elanco Animal Health Inc. slipped as much as 3.3 percent Monday morning after lead managers and other banks involved in its recent initial public offering started coverage on the animal health company.
